Carol Karp

General Counsel at PROTHENA CORPORATION PLC

Net worth: - $ as of 29/04/2024

71 year

Health Technology

Consumer Services

Profile

Carol D.
Karp is currently the Vice Chairman-Trustees Board at Rochester Christian University and the Chief Regulatory Officer at Prothena Corp.
Plc.
Previously, she held positions such as Officer at VIVUS, Inc., SVP-Regulatory Affairs, Quality & Drug Safety at CV Therapeutics, Inc., Senior VP-Regulatory Affairs & Compliance at Esperion Therapeutics, Inc., Vice President-Scientific Affairs at Powderject Technologies BV, and Vice President & Head-Global Regulatory Affairs at Janssen Alzheimer Immunotherapy.
Ms. Karp obtained her undergraduate degree from Rochester Christian University and New York University.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PROTHENA CORP. PLC -.--%	03/03/2024	0 ( -.--% )	- $	29/04/2024

Carol Karp active positions

Companies	Position	Start
PROTHENA CORPORATION PLC	General Counsel	14/12/2016
Rochester Christian University	Director/Board Member	-

All active positions of Carol Karp

Former positions of Carol Karp

Companies	Position	End
ESPERION THERAPEUTICS, INC.	Compliance Officer	31/12/2013
Janssen Alzheimer Immunotherapy	General Counsel	31/12/2012
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	General Counsel	01/05/2011
VIVUS, INC.	Corporate Officer/Principal	-
Powderject Technologies BV	Chief Tech/Sci/R&D Officer	-

See the detail of Carol Karp's experience

Training of Carol Karp

Rochester Christian University	Undergraduate Degree
New York University	Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Carol Karp's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ESPERION THERAPEUTICS, INC.	Health Technology
PROTHENA CORPORATION PLC	Health Technology

Private companies	4
CV Therapeutics, Inc. CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases	Health Technology
Powderject Technologies BV
VIVUS, Inc. VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA.	Health Technology
Janssen Alzheimer Immunotherapy

See company connections